Clorox (CLX) Tops Q1 EPS by 47c; offers guidance

Clorox (NYSE: CLX) reported Q1 EPS of $1.86, $0.47 better than the analyst estimate of $1.39. Revenue for the quarter came in at $1.76 billion versus the consensus estimate of $1.64 billion.

GUIDANCE:

Clorox sees FY2025 EPS of $6.65-$6.90, versus the consensus of $6.65.

For earnings history and earnings-related data on Clorox (CLX) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral